Introduction: Visual disturbances very often accompany of multiple sclerosis (MS) and affect patients' quality of life (QoL). There have been no tools for investigation of the effect of visual disturbances on QoL in MS patients available in Poland. The aim of this study was validation analysis of Polish adaptation of Visual Function Questionnaire VFQ-25.
Material And Methods: VFQ-25 published by Mangione in 2001, consists of 25 questions concerning general well-being, assessment of vision, social functioning, mental health, and self-sufficiency. According to the applicable translation principles, the original English version was adapted into Polish, and validation analysis of the convergent validity as well internal reliability was carried out. 108 randomly selected patients, diagnosed with MS according to McDonald's criteria were included in this study: 63 women and 45 men aged on the average 37.8 +/- 9.2 years, with mean disease duration of 11.2 +/- 5.6 years. All patients underwent assessment of disability based on Expanded Disability Status Scale (EDSS). Besides the analyzed VFQ-25 questionnaire, the patients completed also the Functional Assessment of Multiple Sclerosis (FAMS) questionnaire and SF-36 Health Survey.
Results: The internal consistency of the questionnaire was satisfactory (Cronbach's alpha reached 0.95). The accuracy of the scale was confirmed by positive correlations of the results between VFQ-25 and EDSS, FAMS and SF-36.
Conclusions: Statistical analysis has demonstrated that the Polish version of VFQ-25 is a valuable tool for investigation of the effect of visual disturbances on QoL in MS patients.
Download full-text PDF |
Source |
---|
The most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is an intronic GC repeat expansion in C9orf72. The repeats undergo bidirectional transcription to produce sense and antisense repeat RNA species, which are translated into dipeptide repeat proteins (DPRs). As toxicity has been associated with both sense and antisense repeat-derived RNA and DPRs, targeting both strands may provide the most effective therapeutic strategy.
View Article and Find Full Text PDFBMJ Case Rep
January 2025
Infectious Diseases, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
We present a case of a woman in her 40s with disseminated enterovirus infection in the setting of maintenance therapy with ocrelizumab for relapsing-remitting multiple sclerosis. The patient originally presented with fever, bilateral lower limb swelling and hypoalbuminaemia. She subsequently developed a productive cough and diarrhoea, and a viral respiratory multiplex panel detected rhino/enterovirus.
View Article and Find Full Text PDFBrain Commun
December 2024
UCL Hawkes Institute and UCL Queen Square Institute of Neurology, University College London, London, UK.
This scientific commentary refers to 'A data-driven model of disability progression in progressive multiple sclerosis', by Garbarino . (https://doi.org/10.
View Article and Find Full Text PDFBrain Commun
December 2024
Department of Health Sciences (DISSAL), Università di Genova, 16132 Genoa, Italy.
This study applies the Gaussian process progression model, a Bayesian data-driven disease progression model, to analyse the evolution of primary progressive multiple sclerosis. Utilizing data from 1521 primary progressive multiple sclerosis participants collected within the International Progressive Multiple Sclerosis Alliance Project, the analysis includes 18 581 longitudinal time-points (average follow-up time: 28.2 months) of disability assessments including the expanded disability status scale, symbol digit modalities, timed 25-foot-walk, 9-hole-peg test and of MRI metrics such as T1 and T2 lesion volume and normalized brain volume.
View Article and Find Full Text PDFBiomedicine (Taipei)
December 2024
Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Introduction: Although the HaCaT keratinocyte model has been used in previous research to study the effects of antipsoriatic agents, there is still a lack of comprehensive understanding of the mechanism of imiquimod (IMQ)-induced proliferation and signal transduction in psoriasis-like keratinocytes.
Objectives: This study aimed to investigate the molecular mechanisms and pathways associated with psoriasis-like inflammation caused by IMQ in human keratinocytes.
Materials And Methods: HaCaT cells were exposed to different concentrations of IMQ to induce inflammation similar to that observed in psoriasis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!